Skip to search formSkip to main contentSkip to account menu

Colprone

Known as: Biodim Brand of Medrogestone, Medrogestone Biodim Brand 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Medrogestone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Ménopause: quel progestatif choisir ? de l'intérêt de la médrogestone (colprone) dans le traitement substitutif de la ménopause
1982
1982
Medrogestone and an LHRH analogue as potential combination therapy for hormone-dependent cancers.
Treatment (5 mg/kg s.c. for 1 to 4 weeks) of adult male rats with medrogestone (Colprone), a compound with progestational and… 
1982
1982
Effects of Colprone on in vitro release of androgens from the reproductive organs of the male rat.
1981
1981
Inhibition of testosterone metabolism by medrogestone in rat ventral prostate in vivo and in vitro.
Medrogestone (MDG), viz., 6,17-dimethyl-4,6-pregnadiene-3,20-dione (Colprone), a synthetic compound with progestational and… 
1981
1981
Effect of medrogestone on conversions of pregnenolone and 17 alpha-hydroxypregnenolone in rat testis.
Medrogestone, viz., 6,17-dimethylpregn-4,6-diene,3,20-dione (Colprone), a synthetic compound with progestational and… 
Review
1974
Review
1974
Use of Progestational Agents in Endometrial Adenocarcinoma
Forty-four patients with recurrent or disseminated adenocarcinoma of the endometrium who were treated with progestational agents… 
1974
1974
Measurement of a progestational and antiandrogenic compound by a competitive protein binding assay.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)